Pharmaceutical Commerce - June 2018 - 17

F E AT U R E

Overt, covert and e-labels
trace products, and thus indicate
gray market activities.
All functional components
can be customized and combined
with each other. This results
in complex security labels that
effectively put a stop to the
counterfeiters' game and offer a
wide range of added value to the
pharmaceutical company.

Hu man Vi si ble , O ve rt
Features

Overt features enable fast
authentication by sellers,
pharmacists and consumers
without any extra tools. Optically
variable holograms, for instance,
are based on microscopically Ideally, authenticity features should be selected so that consumers and specialists are involved in the
small, diffractive structures in authentication process.
the film layers, which make the
authentication. These robust and colorless markers can be
feature unique and thus achieve a high level of counterfeiting
invisibly incorporated into any design and implemented
protection. Pharmaceutical manufacturers increasingly
using diverse techniques. A customized formulation with
complement this feature by security color-shifting inks.
an invisible "fingerprint" represents the highest level of
Providers of professional solutions rely on specialty inks
counterfeiting protection, as it can neither be seen, copied
that may only be used by security printing companies.
nor re-engineered.
Manufacturers achieve a particularly high protection level
Digital security features use computer-generated and
by combining these color effects with special printing
highly encrypted encodings as human-readable numbers,
techniques, "latent images" or thermo-reactive inks.
2D codes or special random patterns to enable internetbased authentication in the pharmaceutical supply chain
Machine Visible, Covert Features
all the way to the end user. In addition, digital technologies
Ideally, holistic counterfeiting protection should always
offer direct interaction between the product and the
consist of a combination of overt security features with
person performing the check, and can thus serve to provide
digital and covert technologies.
information and to support promotional activities.
Covert features are especially important for checking
However, due to the possibility of copying them,
suspect products, for complaints and final legal proof. For
numbers and encodings alone are not counterfeit-proof.
this purpose, manufacturers integrate special molecules
Companies should therefore always combine them with
and pigments into the packaging or label. Only a special
additional features. Copy protection patterns, for instance,
detector can prove the presence of these pigments during

06.2018 / Visit our website at www.PharmaceuticalCommerce.com / 17


http://www.PharmaceuticalCommerce.com

Table of Contents for the Digital Edition of Pharmaceutical Commerce - June 2018

Table of Contents
Pharmaceutical Commerce - June 2018 - Cover1
Pharmaceutical Commerce - June 2018 - Cover2
Pharmaceutical Commerce - June 2018 - Table of Contents
Pharmaceutical Commerce - June 2018 - 4
Pharmaceutical Commerce - June 2018 - 5
Pharmaceutical Commerce - June 2018 - 6
Pharmaceutical Commerce - June 2018 - 7
Pharmaceutical Commerce - June 2018 - 8
Pharmaceutical Commerce - June 2018 - 9
Pharmaceutical Commerce - June 2018 - 10
Pharmaceutical Commerce - June 2018 - 11
Pharmaceutical Commerce - June 2018 - 12
Pharmaceutical Commerce - June 2018 - 13
Pharmaceutical Commerce - June 2018 - 14
Pharmaceutical Commerce - June 2018 - 15
Pharmaceutical Commerce - June 2018 - 16
Pharmaceutical Commerce - June 2018 - 17
Pharmaceutical Commerce - June 2018 - 18
Pharmaceutical Commerce - June 2018 - 19
Pharmaceutical Commerce - June 2018 - 20
Pharmaceutical Commerce - June 2018 - 21
Pharmaceutical Commerce - June 2018 - 22
Pharmaceutical Commerce - June 2018 - 23
Pharmaceutical Commerce - June 2018 - 24
Pharmaceutical Commerce - June 2018 - 25
Pharmaceutical Commerce - June 2018 - 26
Pharmaceutical Commerce - June 2018 - 27
Pharmaceutical Commerce - June 2018 - 28
Pharmaceutical Commerce - June 2018 - 29
Pharmaceutical Commerce - June 2018 - 30
Pharmaceutical Commerce - June 2018 - 31
Pharmaceutical Commerce - June 2018 - 32
Pharmaceutical Commerce - June 2018 - 33
Pharmaceutical Commerce - June 2018 - 34
Pharmaceutical Commerce - June 2018 - Cover3
Pharmaceutical Commerce - June 2018 - Cover4
http://www.nxtbook.com/nxtbooks/pharmcomm/201909
http://www.nxtbook.com/nxtbooks/pharmcomm/201906
http://www.nxtbook.com/nxtbooks/pharmcomm/201903
http://www.nxtbook.com/nxtbooks/pharmcomm/201811
http://www.nxtbook.com/nxtbooks/pharmcomm/201809
http://www.nxtbook.com/nxtbooks/pharmcomm/201806
http://www.nxtbook.com/nxtbooks/pharmcomm/20180304
http://www.nxtbook.com/nxtbooks/pharmcomm/20171112
http://www.nxtbook.com/nxtbooks/pharmcomm/20170910
http://www.nxtbook.com/nxtbooks/pharmcomm/20170708
http://www.nxtbook.com/nxtbooks/pharmcomm/20170506
http://www.nxtbook.com/nxtbooks/pharmcomm/20170304
http://www.nxtbook.com/nxtbooks/pharmcomm/20170102
http://www.nxtbook.com/nxtbooks/pharmcomm/20161112
http://www.nxtbook.com/nxtbooks/pharmcomm/20160910
http://www.nxtbook.com/nxtbooks/pharmcomm/20160708
http://www.nxtbook.com/nxtbooks/pharmcomm/20160506
http://www.nxtbook.com/nxtbooks/pharmcomm/20160304
http://www.nxtbook.com/nxtbooks/pharmcomm/20160102
http://www.nxtbook.com/nxtbooks/pharmcomm/20151112
http://www.nxtbook.com/nxtbooks/pharmcomm/20150910
http://www.nxtbook.com/nxtbooks/pharmcomm/20150708
http://www.nxtbook.com/nxtbooks/pharmcomm/20150506
http://www.nxtbook.com/nxtbooks/pharmcomm/20150304
http://www.nxtbook.com/nxtbooks/pharmcomm/20150102
http://www.nxtbook.com/nxtbooks/pharmcomm/20141112
http://www.nxtbook.com/nxtbooks/pharmcomm/coldchaindirectory2014
http://www.nxtbook.com/nxtbooks/pharmcomm/20140910
http://www.nxtbook.com/nxtbooks/pharmcomm/20140708
http://www.nxtbook.com/nxtbooks/pharmcomm/20140506
http://www.nxtbook.com/nxtbooks/pharmcomm/20140304
http://www.nxtbook.com/nxtbooks/pharmcomm/20140102
http://www.nxtbook.com/nxtbooks/pharmcomm/dataservicedirectory
http://www.nxtbook.com/nxtbooks/pharmcomm/20131112
http://www.nxtbook.com/nxtbooks/pharmcomm/20130910_hubreport
http://www.nxtbook.com/nxtbooks/pharmcomm/20130910
http://www.nxtbook.com/nxtbooks/pharmcomm/20130708
http://www.nxtbook.com/nxtbooks/pharmcomm/20130506
http://www.nxtbook.com/nxtbooks/pharmcomm/coldchain2013
http://www.nxtbook.com/nxtbooks/pharmcomm/20130304
http://www.nxtbook.com/nxtbooks/pharmcomm/20130102
http://www.nxtbook.com/nxtbooks/pharmcomm/20121112
http://www.nxtbook.com/nxtbooks/pharmcomm/20120910
http://www.nxtbook.com/nxtbooks/pharmcomm/20120708
http://www.nxtbook.com/nxtbooks/pharmcomm/20120506
http://www.nxtbook.com/nxtbooks/pharmcomm/20120506_coldchain
http://www.nxtbook.com/nxtbooks/pharmcomm/20120304
http://www.nxtbook.com/nxtbooks/pharmcomm/20120102
http://www.nxtbook.com/nxtbooks/pharmcomm/20111112
http://www.nxtbook.com/nxtbooks/pharmcomm/20110910
http://www.nxtbook.com/nxtbooks/pharmcomm/20110708
http://www.nxtbook.com/nxtbooks/pharmcomm/20110506
http://www.nxtbook.com/nxtbooks/pharmcomm/20110304
http://www.nxtbook.com/nxtbooks/pharmcomm/20110102
http://www.nxtbook.com/nxtbooks/pharmcomm/20101112
http://www.nxtbook.com/nxtbooks/pharmcomm/20100910
http://www.nxtbook.com/nxtbooks/pharmcomm/20100708
http://www.nxtbook.com/nxtbooks/pharmcomm/20100506
http://www.nxtbook.com/nxtbooks/pharmcomm/201004
http://www.nxtbook.com/nxtbooks/pharmcomm/201003
http://www.nxtbook.com/nxtbooks/pharmcomm/20100102
http://www.nxtbook.com/nxtbooks/pharmcomm/20091112
http://www.nxtbookMEDIA.com